The binding of antibiotics to serum proteins.

  title={The binding of antibiotics to serum proteins.},
  author={George Newbolt Rolinson and Robert Sutherland},
  journal={British journal of pharmacology and chemotherapy},
  volume={25 3},
ultrafiltration Visking dialysis tubing. Preliminary experiments indicated that there was no significant difference between the extent of binding in plasma obtained from heparinized blood and that in serum. The antibiotic present in the protein-free ultrafiltrate was measured by microbiological assay and this quantity represented the free, unbound, fraction of antibiotic in serum. The amount of antibiotic bound to protein was derived by subtracting the level of free antibiotic from the known… 

Figures and Tables from this paper

Binding of Antibiotics to Bovine and Ovine Serum
  • G. Ziv, F. Sulman
  • Medicine, Biology
    Antimicrobial Agents and Chemotherapy
  • 1972
The capacity of bovine or ovine serum to bind antibiotics was, with a few exceptions, similar to the reported capacity of human serum.
Studies on the relationship of protein binding and gel-affinity of antibiotics including penicillins.
The batchwise method was used, by which, a similar relationship between the extent of protein binding and the corresponding gelaffinity was elucidated, and the amount of binding to serum proteins could be predicted without using serum.
Influence of protein binding of antibiotics on serum pharmacokinetics and extravascular penetration: clinically useful concepts.
The extravascular distribution, tissue binding, and free-drug concentration of an antibiotic can be accurately predicted from serum kinetics and serum protein binding.
Protein Binding of Antimicrobials: Clinical Pharmacokinetic and Therapeutic Implications
Tissue and extravascular fluid drug levels are primarily influenced by the free drug levels in serum, but calculation of actual tissue levels is complicated by variable binding characteristics of specific tissues and tissue fluids, and also by the lipophilic nature of the drug.
The effects of protein-binding on distribution of antibiotics and the problem of continuous versus intermittent infusions
  • M. Barza
  • Chemistry, Medicine
  • 2005
Findings are discussed in terms of some controversial aspects of the effects of proteinbinding on therapeutic efficacy, peak serum levels of antibiotic, rates of elimination and distribution within the body.
Effect of protein binding on serum bactericidal activities of ceftazidime and cefoperazone in healthy volunteers.
Serum bactericidal activity was more closely related to unbound rather than total antibiotic concentrations, supporting the concept that only the unbound drug is microbiologically active.
Rate of Binding of Antibiotics to Canine Serum Protein
The data from this study indicate that prolonged rates of binding of highly protein-bound drugs may influence pharmacological studies and appears directly related to the total percentage bound.
The effect of disease states on serum protein binding of antimicrobials
SummarySerum protein binding of antimicrobials is altered in various disease states. In uremia, the binding of many organic acids to serum proteins is reduced. The defect in binding is 1. greater
Comparative study of the binding of acylureidopenicillins and carbenicillin to human serum proteins
The interaction between acylureidopenicillins and serum proteins is mainly hydrophobic in nature, which can be deduced from the fact that for example in the presence of sisomicin azlocillin is not displaced from its albumin binding site, in contrast to carbenicillin.
Displacement from protein binding of sulphormethoxine by phenylbutazone using in vivo dialysis in rats
These experiments indicated the relationships between the relative affinities of sulphormethoxine and phenylbutazone for serum proteins and the extent to which mutual displacement from binding occurred.


The relation between the binding of sulfonamides to albumin and their antibacterial efficacy.
  • A. Anton
  • Biology, Chemistry
    The Journal of pharmacology and experimental therapeutics
  • 1960
It was found that the plasma binding of sulfonamides may be markedly different among various vertebrate species and Phenylbutazone was found to interfere significantly with the binding of a sulfonamide to albumin.
Studies on Binding of Tetracyclines by Dog and Human Plasma.∗
  • L. A. Wozniak
  • Materials Science
    Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine
  • 1960
Summary Dialysis equilibrium studies under physiological conditions of temperature and pH with tetracycline, demethylchlortetracycline and chlortetracycline have shown that degree of binding by dog
Enhancement of Antimicrobial Activity of Penicillins and Other Antibiotics in Human Serum by Competitive Serum Binding Inhibitors.∗
  • C. Kunin
  • Biology, Medicine
    Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine
  • 1964
Evidence is presented that the “R” groups of penicillins are the most important determinants of binding to serum, and the specificity of the penicillin binding sites was shown.
The Relation of Protein Binding to the Pharmacology and Antibacterial Activity of Penicillins X, G, Dihydro F, and K
By the end of 1945, evidence had been accumulated which would indicate: (a) that penicillin G would bind to purified albumin and to a constituent of serum which presumably was albumin; and (b) that there was a substance or that the portion of the drug which is bound is inactive against bacteria.
Antibacterial activity of serum after oral doses of tetracycline, demethylchlortetracycline, and 6‐methyleneoxytetracycline
Studies in man indicate that tetracycline and 6‐methyleneoxytetracycline are absorbed more rapidly after oral administration than demethylchlortetracycline but that the antibacterial activity of the
Oxacillin: laboratory and clinical evaluation.
Clinical results in 68 patients were good, and the authors conclude that, where oral therapy is feasible, oxacillin is a potent agent for treating infections caused by penicillin G-resistant staphylococci.
A Comparison of Four Phenoxypenicillins
Evidence made available to support the different claims has not been convincing, and the need for a comparison of all four derivatives was pointed out by the British Medical Journal (1962).